Surgical implantation of a bioengineered internal anal sphincter

Journal of Pediatric Surgery

Volumn 45, Issue 1, 2010, Pages 52-58

  Hashish, Mohamed ^a   Raghavan, Shreya ^b   Somara, Sita ^b   Gilmont, Robert R ^b   Miyasaka, Eiichi ^a   Bitar, Khalil N ^b   Teitelbaum, Daniel H ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Fibroblastic growth factor 2; Incontinence; Internal anal sphincter; Tissue engineering

Indexed keywords

FIBROBLAST GROWTH FACTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANUS SPHINCTER; ARTICLE; BIOENGINEERING; CELL VIABILITY; CONTROLLED STUDY; FECES INCONTINENCE; FEMALE; GRAFT SURVIVAL; IMPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE; VASCULARIZATION;

ANAL CANAL; ANIMALS; BIOMEDICAL ENGINEERING; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FECAL INCONTINENCE; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; MANOMETRY; MICE; MICE, INBRED C57BL; MUSCLE, SMOOTH; MYOCYTES, SMOOTH MUSCLE; PROSTHESIS DESIGN; PROSTHESIS IMPLANTATION; TISSUE CULTURE TECHNIQUES; TISSUE ENGINEERING;

EID: 72649101995     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2009.10.010     Document Type: Article

References (37)

1. Nelson R., Norton N., Cautley E., et al. Community-based prevalence of anal incontinence. JAMA 274 (1995) 559-561
2. Perry S., Shaw C., McGrother C., et al. Prevalence of faecal incontinence in adults aged 40 years or more living in the community. Gut 50 (2002) 480-484
3. Sultan A.H., Kamm M.A., Hudson C.N., et al. Third degree obstetric anal sphincter tears: risk factors and outcome of primary repair. BMJ 308 (1994) 887-891
4. Jones O.M., Brading A., and Mortensen N. The physiology, pharmacology and therapeutic manipulation of the internal anal sphincter. Can J GastroenteroI 16 (2002) 249-257
5. da Silva G., Jorge J., Belin B., et al. New surgical options for fecal incontinence in patients with imperforate anus. Dis Colon Rectum 47 (2004) 204-209
6. Whitehead W., Wald A., and Norton N. Treatment options for fecal incontinence. Dis Colon Rectum 44 (2001) 131-142
7. Dennis R., and Kosink I.P. Excitability and isometric contractile properties of mammalian skeletal muscle contructs engineered in vitro. In Vitro Cell Dev Biol Anim 36 (2000) 327-335
8. Dennis R.G., Kosnik P.E., Gilbert M.E., et al. Excitability and contractility of skeletal muscle engineered from primary cultures and cell line. Am J Physiol Cell Physiol 280 (2001) 288-295
9. Dennis R., and Kosink I.P. Mesenchymal cell culture: instrumentation and methods for evaluating engineered muscle. In: Atala A., and Lanza R. (Eds). Methods in tissue engineering (2002), Academic, San Diego (Calif) 9
10. Hecker L., Baar K., Dennis R., et al. Development of a three-dimensional physiological model of the internal anal sphincter bioengineered in vitro from isolated smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 289 (2005) 188-196
11. Bitar K., and Makhlouf G. Relaxation of isolated gastric smooth muscle cells by vasoactive intestinal peptide. Science 216 (1982) 513-533
12. Bitar K.N., and Makhlouf G.M. Specific opiate receptors on isolated mammalian gastric smooth muscle cells. Nature 297 (1982) 72-74
13. Birla R.K., Borschel G.H., and Dennis R.G. In vivo conditioning of tissue-engineered heart muscle improves contractile performance. Artificial Organs 29 (2005) 866-875
14. Shimizu T., Yamato M., Isoi Y., et al. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 90 (2002) e40
15. Eschenhagen T., Didie M., Munzel F., et al. 3D engineered heart tissue for replacement therapy. Basic Res Cardiol 97 (2002) I146-I152
16. Selden R., Skoskiewicz M., Howie K., et al. Implantation of genetically engineered fibroblasts into mice: implications for gene therapy. Science 236 (1987) 714-718
17. Nisolle M., Casanas-Roux F., Marbaix E., et al. Transplantation of cultured explants of human endometrium into nude mice. Hum Reprod 15 (2000) 572-577
18. Mazue G., Bertolero F., Jacob C., et al. Preclinical and clinical studies with recombinant human basic fibro broblast growth factor. Ann N Y Acad Sci 638 (1991) 3329-3340
19. Steffens L., Wenger A., Stark G.B., et al. In vivo engineering of a human vasculature for bone tissue engineering applications. J Cell Mol Med (2009) [Epub ahead of print]
20. Davies M., Burke D., Carnochan P., et al. Basic fibroblast growth factor infusion increases tumour vascularity, blood flow and chemotherapy uptake. Acta Oncol 41 (2002) 84-90
21. Uhl E., Barker J.H., Bondar I., et al. Basic fibroblast growth factor accelerates wound healing in chronically ischaemic tissue. Br J Surg 80 (1993) 977-980
22. Lindner V., Majack R.A., and Reidy M.A. Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries. J Clin Invest 85 (1990) 2004-2008
23. Roberts-Clark D.J., and Smith A.J. Angiogenic growth factors in human dentine matrix. Arch Oral Biol 45 (2000) 1013-1016
24. Tang A.T.M., Hasleton P.S., Heid H., et al. Quantification of early damage in latissimus dorsi muscle grafts. Muscle Nerve 21 (1998) 1451-1456
25. Kwan M., Tam E., Lo S., et al. The time effect of pressure on tissue viability: investigation using an experimental rat model. Exp Biol Med 232 (2002) 481-487
26. Bursac N., Papadaki M., Cohen R.J., et al. Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. Am J Physiol Cell Physiol 277 (1999) H433-H444
27. Baek C.H., and Ko Y.J. Characteristics of tissue-engineered cartilage on macroporous biodegradable PLGA scaffold. Laryngoscope 116 (2006) 1829-1834
28. Sakai T., Li R.K., Weisel R.D., et al. The fate of a tissue-engineered cardiac graft in the right ventricular outflow tract of the rat. J Thorac Cardiovasc Surg 121 (2001) 932-942
29. Leor J., Aboulafia-Etzion S., Dar A., et al. Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium?. Circulation 102 (2000) III56-III61
30. El-Akouri R.R., Molne J., Groth K., et al. Rejection patterns in allogeneic uterus transplantation in the mouse. Hum Reprod 21 (2006) 436-442
31. Griffith C.K., Miller C., Sainson R.C., et al. Diffusion limits of an in vitro thick prevascularized tissue. Tissue Eng 11 (2005) 257-266
32. Marra K.G., Defail A.J., Clavijo-Alvarez J.A., et al. FGF-2 enhances vascularization for adipose tissue engineering. Plast Reconstr Surg 121 (2008) 1153-1164
33. Urquhart J., Fara J.W., and Willis K.L. Rate-controlled delivery systems in drug and hormone research. Annu Rev Pharmacol Toxicol 24 (1984) 199-236
34. Scholz D., Ziegelhoeffer T., Helisch A., et al. Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice. J Mol Cell Cardiol 34 (2002) 775-787
35. Xia Z., Taylor P.R., Locklin R.M., et al. Innate immune response to human bone marrow fibroblastic cell implantation in CB17 scid/beige mice. J Cell Biochem 98 (2006) 966-980
36. Samsudin O.C., Aminuddin B.S., Munirah S., et al. In vitro development of autologous tissue engineered human articular neocartilage for orthopaedic surgery. Med J Malaysia 59 Suppl B (2004) 15-16
37. Somara S., Gilmont R.R., Dennis R.G., and Bitar K.N. Bioengineered internal anal sphincter derived from isolated human internal anal sphincter smooth muscle cells. Gastroenterology 137 1 (2009) 53-61